Brief: Gentian Diagnostics Q3 Operating Loss Widens To NOK 8.7 Mln

Gentian Diagnostics ASA

27/10/2022 07:16

Oct 27 (Reuters) - Gentian Diagnostics ASA  GENT.OL :
    * THIRD QUARTER 2023 REPORT
    * Q3 SALES REVENUE OF MNOK 23.1 IN 3Q22, AN INCREASE OF 34%
(35%
ORGANIC GROWTH)
    * ADDITIONAL US DISTRIBUTION AGREEMENT FOR CYSTATIN C
ANNOUNCED IN
AUGUST 2022 IS EXPECTED TO SUPPORT REVENUE GROWTH FROM 2023
    * Q3 OPERATING LOSS NOK 8.7 MILLION VERSUS LOSS NOK 6.6
MILLION
YEAR AGO

Source text for Eikon:  ID:nObiXt6dLa 
Further company coverage:  GENT.OL 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))